HIV-1 dynamics in children

HIV-l-infected children have higher plasma viral lends and progress to dise ase more quickly than infected adults. To gain insight into the accelerated pathogenesis of HIV-1 in children, viral dynamics were measured following the initiation of highly active antiretroviral therapy (HAART) and compared with those reported for adults. A biphasic decline in plasma HIV-I RNA was observed, with a rapid decrease during the first 1 to 2 weeks of therapy ( phase I) followed by a slower decline (phase II). The phase I and II decay rates were not significantly different among children of different ages, pr etherapy plasma HIV-I RNA levels, or CD4 cell counts. Estimated phase I dec ay rates were similar to those previously reported in adults with a mean of 0.43 days(-1) and a half-life of 1.6 days. The phase II decay rates were s lower in children compared with adults with a mean of 0.016 days(-1) versus 0.066 days(-1), and a half-life of 43.3 versus 14.1 days, respectively (p <.05). The mean time required to reach viral levels below detection thresho lds was also longer in these children compared with that in adults. These d ata suggest that HIV-1 dynamics may be different in children, and that thes e differences may necessitate different treatment strategies.